KL*VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE*4 carriers (2021)

First Author: Belloy M
Attributed to:  MICA: Medical Bioinformatics: Data-Driven Discovery for Personalised Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.neurobiolaging.2021.01.008

PubMed Identifier: 33610961

Publication URI: http://europepmc.org/abstract/MED/33610961

Type: Journal Article/Review

Parent Publication: Neurobiology of Aging

ISSN: 0197-4580